Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6afdc1e0f3dd807c5e828116fa6cfe1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_954b39aa4ea556272616bfb1407a2991 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_788b0824eef429d2a0ab57532ec5718f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f6df69892ee4952d14e6f75a12ffeb0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-044 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F5-0076 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-04 |
filingDate |
2013-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d66687cfeb0b9f5fdbdde7db75b604a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f5ead2f249e0f620199475211efed3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e73dfa3b5a6d58c85bfdba37f7576056 |
publicationDate |
2015-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9149614-B2 |
titleOfInvention |
Systems and methods for treatment of obesity and type 2 diabetes |
abstract |
The present invention provides systems and methods for treating and controlling obesity and/or type II diabetes. In one aspect of the invention, a device comprises a hollow sleeve sized and shaped for positioning within a duodenum of the patient, an anchor coupled to the proximal end of the sleeve and being sized and shaped to inhibit distal migration of the sleeve and a plurality of elastomeric objects coupled to the distal end of the sleeve and being sized and shaped to inhibit proximal migration of the sleeve through a pylorus of the patient. The bypass device can be placed and removed endoscopically through the patient's esophagus in a minimally invasive outpatient procedure and it is “self-anchoring” and does not require invasive tissue fixation within the patient's GI tract, thereby reducing collateral tissue damage and minimizing its impact on the digestive process. |
priorityDate |
2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |